Some compounding pharmacies offer intermediate doses that allow for smaller increments between levels
During the transition: Monitor blood glucose more frequently for the first 4 to 6 weeks Expect potential hypoglycemia risk if also taking insulin or sulfonylureas Your provider may need to adjust other diabetes medications A1C improvements may be more pronounced with tirzepatide The SURPASS clinical trials demonstrated that tirzepatide 15 mg reduced A1C by up to 2.58%, compared to semaglutide 1 mg which reduced A1C by 1.86%
Sci Rep 15 , 34673 (2025)
It's important to raise the dose gradually as it gives your body time to adjust to the medication
We serve patients in Bucks County, Montgomery County, Mercer County, and Princeton and Trenton, NJ
20, 2024 American Heart Association Journal, GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes, Dec